| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.26 | 6e-06 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-06 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.23 | 0.0001 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |